Get the Stockscreener App
0.00
100.00%
-334.75
ShockWave Medical Inc stock is currently priced at $0.00, with a 24-hour trading volume of 0.
It has seen a -100.00% decreased in the last 24 hours and a -100.00% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $334.8 pivot point. If it approaches the $334.5 support level, significant changes may occur.
Previous Close:
$334.75
Open:
$0
24h Volume:
0
Market Cap:
$12.57B
Revenue:
$787.97M
Net Income/Loss:
$163.50M
P/E Ratio:
0.00
EPS:
6.42
Net Cash Flow:
$166.14M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1D Range:
$0.00
$0.00
52W Range:
$0.00
$334.90
ShockWave Medical Inc Stock (SWAV) Company Profile
Name
ShockWave Medical Inc
Sector
Industry
Phone
510-279-4262
Address
5403 Betsy Ross Drive, Santa Clara
ShockWave Medical Inc Stock (SWAV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-29-23 | Initiated | UBS | Neutral |
| Jul-10-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-15-23 | Initiated | Needham | Buy |
| Dec-16-22 | Initiated | Deutsche Bank | Buy |
| Dec-12-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Sep-06-22 | Downgrade | Oppenheimer | Perform → Underperform |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-06-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-15-21 | Initiated | SVB Leerink | Outperform |
| Jul-12-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-18-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-11-21 | Upgrade | BofA Securities | Neutral → Buy |
| May-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-20-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-01-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-11-20 | Upgrade | Oppenheimer | Underperform → Perform |
| Apr-01-20 | Downgrade | Oppenheimer | Perform → Underperform |
| Feb-21-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Oct-21-19 | Initiated | Piper Jaffray | Overweight |
| Jun-13-19 | Reiterated | BofA/Merrill | Neutral |
| Apr-01-19 | Initiated | BofA/Merrill | Neutral |
| Apr-01-19 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-01-19 | Initiated | Wells Fargo | Market Perform |
View All
ShockWave Medical Inc Stock (SWAV) Latest News
Johnson & Johnson completes $13.1B acquisition of Shockwave Medical - NJBIZ
NJBIZ
Johnson & Johnson finalizes Shockwave Medical acquisition - Investing.com ZA - Investing.com South Africa
Investing.com South Africa
It's official: Johnson & Johnson completes $13B Shockwave Medical acquisition - Cardiovascular Business
Cardiovascular Business
Johnson and Johnson Completes Acquisition of Shockwave Medical - Diagnostic and Interventional Cardiology
Diagnostic and Interventional Cardiology
Johnson & Johnson completes acquisition of Shockwave Medical - ROI-NJ.com
ROI-NJ.com
Johnson & Johnson finalizes Shockwave Medical acquisition By Investing.com - Investing.com
Investing.com
ShockWave Medical Inc Stock (SWAV) Financials Data
ShockWave Medical Inc (SWAV) Revenue 2024
SWAV reported a revenue (TTM) of $787.97 million for the quarter ending March 31, 2024, a +41.42% rise year-over-year.
ShockWave Medical Inc (SWAV) Net Income 2024
SWAV net income (TTM) was $163.50 million for the quarter ending March 31, 2024, a -32.05% decrease year-over-year.
ShockWave Medical Inc (SWAV) Cash Flow 2024
SWAV recorded a free cash flow (TTM) of $166.13 million for the quarter ending March 31, 2024, a +37.61% increase year-over-year.
ShockWave Medical Inc (SWAV) Earnings per Share 2024
SWAV earnings per share (TTM) was $4.28 for the quarter ending March 31, 2024, a -32.49% decline year-over-year.
ShockWave Medical Inc Stock (SWAV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FRANCIS LAURA | Director |
Mar 26 '24 |
Option Exercise |
6.59 |
1,500 |
9,882 |
2,733 |
| Zacharias Isaac | President, CCO |
Mar 26 '24 |
Sale |
287.67 |
4,000 |
1,150,680 |
56,818 |
| FRANCIS LAURA | Director |
Mar 26 '24 |
Sale |
300.00 |
1,500 |
450,000 |
3,551 |
| WATKINS FRANK T | Director |
Mar 06 '24 |
Option Exercise |
3.42 |
2,000 |
6,832 |
6,532 |
| WATKINS FRANK T | Director |
Mar 06 '24 |
Sale |
253.65 |
2,000 |
507,294 |
4,532 |
| Phung Trinh | VP, Finance |
Mar 06 '24 |
Sale |
253.14 |
21 |
5,316 |
31,024 |
| Zacharias Isaac | President, CCO |
Feb 26 '24 |
Sale |
260.36 |
4,000 |
1,041,440 |
61,372 |
| Phung Trinh | VP, Finance |
Feb 22 '24 |
Sale |
259.24 |
599 |
155,285 |
31,031 |
| MOLL FREDERIC H | Director |
Feb 21 '24 |
Sale |
257.39 |
60,000 |
15,443,412 |
287,521 |
| FRANCIS LAURA | Director |
Feb 16 '24 |
Option Exercise |
6.59 |
1,000 |
6,588 |
2,233 |
About ShockWave Medical Inc
ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
0.28%
0.15%
Cap:
|
Volume (24h):